Ventas (VTR) Stock News

Ventas (NYSE: VTR) announced a quarterly cash dividend of $0.48 per common share. The Board declared the dividend on December 10, 2025, payable on January 15, 2026 to shareholders of record at the close of business on December 31, 2025.

Ventas is an S&P 500 real estate investment trust with about 1,400 properties across North America and the United Kingdom, including over 850 senior housing communities and various medical, research and outpatient facilities.

Ventas (NYSE: VTR) said management will participate in investor meetings at Nareit’s REITworld 2025 Annual Conference on December 8-9, 2025.

Written materials expected for the meetings will be posted on the company website on Monday, December 8, 2025 at 8:30 a.m. ET and archived at ir.ventasreit.com/events-and-presentations for a limited period.

Company background: Ventas is an S&P 500 real estate investment trust with approximately 1,400 properties across North America and the UK and over 850 senior housing communities, plus outpatient medical buildings, research centers and healthcare facilities.

Ventas (NYSE: VTR) priced an underwritten public offering of $500.0 million aggregate principal amount of 5.000% Senior Notes due February 15, 2036 at an issue price of 99.510%. The notes will be senior unsecured obligations of Ventas Realty, fully and unconditionally guaranteed by Ventas. The sale is expected to close on December 4, 2025, subject to customary closing conditions. The company intends to use proceeds for general corporate purposes, which may include repayment of other indebtedness, and to pay offering fees and expenses. Joint book-runners include Wells Fargo, BBVA Securities, J.P. Morgan, Mizuho and RBC Capital Markets.

Ventas (NYSE: VTR) announced that Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research and CEO of Lillibridge Healthcare Services, intends to retire effective May 1, 2026. The company will commence a search for his successor.

Bulgarelli joined Ventas in 2018 after a 28-year career at Jones Lang LaSalle and oversees Ventas’s Outpatient Medical & Research, Triple-Net Leased Healthcare businesses and wholly owned Lillibridge property management and leasing operations. Management praised his role in strengthening client relationships, expanding competitive advantages, and achieving industry-leading tenant satisfaction and retention. Bulgarelli said he will remain engaged to support a smooth transition.

Ventas (NYSE: VTR) reported Q3 2025 results for the quarter ended September 30, 2025, showing operational strength driven by senior housing.

Key metrics: Attributable net income per share $0.14, Normalized FFO $0.88 per share (+10% YoY), Total Company NOI +20% YoY and Same-Store Cash NOI +8% YoY. The senior housing operating portfolio (SHOP) posted Same-Store Cash NOI +16% YoY, revenue +8% and margin expansion of 200 bps. Year-to-date through October 2025 Ventas closed $2.2B of senior housing investments and raised 2025 SHOP investment guidance to $2.5B. Liquidity was $4.1B and Net Debt-to-Further Adjusted EBITDA improved to 5.3x.

Ventas (NYSE: VTR) will release third quarter 2025 earnings after market close on Wednesday, October 29, 2025. A conference call to discuss results is scheduled for Thursday, October 30, 2025 at 10:00 a.m. ET (9:00 a.m. CT).

Dial-in numbers: (888) 330-3576 (US) or +1 (646) 960-0672 (international); participant passcode 7655497. A live webcast and replay will be available from the Investor Relations section of www.ventasreit.com. Telephonic replay will be available for 30 days at (800) 770-2030 or +1 (609) 800-9909 (passcode 7655497).

Venta's portfolio includes approximately 1,400 properties across North America and the UK, including more than 850 senior housing communities, outpatient medical buildings, research centers and healthcare facilities.

Ventas (NYSE:VTR), a leading S&P 500 REIT focused on aging population facilities, has declared a quarterly dividend of $0.48 per common share. The dividend will be paid on October 16, 2025, to stockholders of record as of September 30, 2025.

The company maintains a substantial portfolio of approximately 1,400 properties across North America and the United Kingdom, including over 850 senior housing communities, outpatient medical buildings, research centers, and healthcare facilities. Ventas leverages its Ventas OI™ platform for data-driven insights and operational expertise to serve the growing longevity economy.

Ventas (NYSE:VTR), a leading S&P 500 REIT focused on healthcare and senior living properties, has announced the availability of presentation materials for their upcoming appearance at the BofA Securities 2025 Global Real Estate Conference on September 10, 2025.

The company maintains a substantial portfolio of approximately 1,400 properties across North America and the United Kingdom, including 850 senior housing communities. Ventas's portfolio also encompasses outpatient medical buildings, research centers, and healthcare facilities, positioning it as a key player in the longevity economy.

Ventas (NYSE:VTR), a leading healthcare REIT, has released its 2024-2025 Corporate Sustainability Report highlighting initiatives to support growth amid accelerating senior housing demand. The report focuses on three key pillars: sustainable business practices, exceptional employee development, and high corporate governance standards.

CEO Debra A. Cafaro emphasized the company's strategic positioning to capture multiyear growth opportunities in senior housing through its scale, capital access, and operational expertise. The company's sustainability efforts earned recognition including Nareit's inaugural "Impact at Scale" award and its eighth "Leader in the Light" award for Healthcare in 2024.